Lifestyle

LOTTE WELLFOOD Reports 3rd-Quarter Operating Profit of 89.9 Billion Won… Up 29.7% Year-Over-Year

Revenue of 1.1739 trillion won, up 1.5% year-over-year Cumulative Operating Profit Up 58.7% in Q1–Q3… Revenue Up 5%

Kim Ji-woo
2026-11-11 11:09:24
[Edaily Reporter Kim Ji-woo ] LOTTE WELLFOOD(280360)saw its revenue growth slow in the third quarter of this year, but improved profitability by increasing operating profit by approximately 30% year-over-year.

LOTTE WELLFOOD CI. (Source: LOTTE WELLFOOD)

LOTTE WELLFOOD announced on the 11th that its consolidated operating profit for the third quarter of this year was 89.9 billion won, a 29.7% increase compared to the same period last year.
Revenue for the same period rose 1.5% to 1.1739 trillion won. Net income was 51.9 billion won, up 4.0% year-over-year.

Profitability improved as the growth rate of operating profit significantly outpaced that of revenue. The third-quarter operating profit margin was approximately 7.7%, up about 1.7 percentage points from the same period last year (6.0%).

On a standalone basis, revenue declined, but operating profit increased. Third-quarter standalone revenue was 918.2 billion won, down 1.7% year-over-year. In contrast, operating profit rose 10.3% to 69.4 billion won.

Year-to-date performance also improved. Cumulative consolidated revenue for the first three quarters totaled 3.3569 trillion won, a 5.0% increase compared to the same period last year. Cumulative operating profit for the same period rose 58.7% to 190.4 billion won. Cumulative net income increased 18.5% to 104.7 billion won.

LOTTE WELLFOOD is scheduled to hold an investor briefing for institutional investors and analysts at 2:00 p.m. today to discuss its third-quarter financial results and future business outlook.

Economy

Corporation

IT·Science

Economy

SamsungElectronics Earns 'Top Rating' in Shared Growth Evaluation for 15 Consecutive Years… First Among Korean Companies

SamsungElectronics has become the first South Korean company to receive the highest rating in the Shared Growth Index evaluation for 15 consecutive years. The company was recognized for its contributi…
2026-11-11 12:00:05

Corporation

“Radiopharmaceutical Powerhouse” Cellbion Co., Ltd Heats Up “BioEurope”… Sets Sights on Global Licensing Deal for New Prostate Cancer Drug

#Cellbion Co., Ltd, a company specializing in the development of new radiopharmaceuticals (RPT), is accelerating efforts to secure global technology licensing (L/O) and establish joint development par…
2026-11-11 11:46:02

IT·Science

SKT, KTCorporation Ranks 'Top' on Shared Growth Index for 14 Consecutive Years… Only Two Korean Companies Achieve This

SKTelecom(017670)has once again proven its status as a leading company in Korea committed to mutual growth by earning the highest rating in the Shared Growth Index evaluation for the 14th consecutive …
2026-11-11 12:00:04